ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO2332

Typical Hemolytic Uremic Syndrome in Children: A Single-Center Experience

Session Information

Category: Pediatric Nephrology

  • 1700 Pediatric Nephrology


  • Shah, Siddharth A., University of Louisville, Prospect, Kentucky, United States

Typical hemolytic-uremic syndrome (HUS) associated with diarrhea can be a fatal disease in children. Diarrhea and blood-stained stools are early symptoms. Oliguria and renal failure can occur anywhere from 3-7 days after onset of diarrhea. Intravenous (iv) fluids in the initial timeline of disease presentation may decrease the need for dialysis. Oligo-anuria at admission and leukocytosis is associated with poor outcomes during hospitalization. After recovery, there is a risk of long-term renal complications such as hypertension, proteinuria, and chronic kidney disease (CKD).


We performed a retrospective analysis of 43 children admitted with diarrhea associated with HUS at our center in the last ten years. The 'late presentation' defined as serum creatinine>1 mg/dL, oliguria, or anuria at admission. The primary outcome was the presence of long-term renal sequelae. It included proteinuria, hypertension, or chronic kidney disease (CKD) (eGFR <75 ml/min/1.73m2) after one year of disease-onset. The Chi-square and correlation analysis performed on the SPSS platform.


Overall, 32/43 presented late in the disease course, 30/43 required dialysis (median: 8 d), and 8/43 had a recent history of NSAID use. The administration of dextrose and saline containing iv fluids in the early presentation was associated with the decreased requirement of dialysis (p=0.042), but the effect was not significant with NSAID use (p=0.064). Peak white blood cell count (Wbc) had a strong correlation with days of hospitalization (p<0.001). 10/43 children were lost to follow up. 13/33 children showed renal sequelae (includes 3 with CKD and 1 with ESRD who required kidney transplant) after one year of disease onset. Wbc count >20000 cells/mm3 (at p=0.001) and duration of dialysis>14 days (at p=0.002) were associated significantly with the primary outcome. 6/43 children were un-immunized. There was no mortality.


High peak WBC count may be a useful prognostic marker to evaluate the risk of long-term renal complications. These children need monitoring periodically after disease recovery. Early diagnosis and iv fluids before the onset of renal failure may help to prevent dialysis-related morbidity at the time of admission. More awareness is needed to discourage the use of NSAIDs following initial symptoms of HUS.